BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY

• 收藏
• 分享

专利权人:

S.A.U.;TiGenix

发明人:

Olga DE LA ROSA,Wiltried DALEMANS

申请号：

US15568563

公开号：

US20180156785A1

申请日:

2016.04.25

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The invention relates to a method for predicting the clinical response to a therapy based on the administration of mesenchymal stem cells (MSCs) in a patient suffering from an immune-mediated inflammatory disease. The invention also relates to methods of personalised medicine as well as to therapeutic uses of MSCs in a patient suffering from an immune-mediated inflammatory disease.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/